Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SORD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETSIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC25A15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNMT3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC9A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060363 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBR3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAAF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on